Health Commissioner Persichilli Statement on CDC Recommendation on Pfizer Booster for Ages 6 Months to 4 Years Old
Children in this age group who completed their Pfizer primary series with the monovalent vaccine more than two months ago are now eligible to receive a single booster dose of Pfizer’s bivalent vaccine.
The recommendation by the CDC follows the U.S. Food and Drug Administration’s (FDA) expanded authorization on March 14.
As of December 2022, children 6 months through 4 years of age who received the first two doses with monovalent Pfizer vaccine are recommended to complete their three-dose primary series with the Pfizer bivalent COVID-19 vaccine. These children are not eligible or recommended to receive an additional booster dose of a bivalent vaccine at this time. Children 6 months through 4 years of age who previously completed a Moderna primary series remain eligible to receive a Moderna bivalent booster at least two months after completing their 2 dose primary series.
The COVID-19 vaccines and boosters continue to be safe and effective – serving as our most potent tool against serious illness. Getting vaccinated and staying up to date on boosters offers individuals the best protection against COVID-19 and remains an important part of our State’s fight against the virus.
I encourage individuals who are eligible for the vaccine or booster to visit covid19.nj.gov/finder to locate a vaccine appointment or reach out to the Vaccine Call Center at 855-568-0545. Residents age 65 and older can reach the call center’s senior hotline at 855-429-1168 for assistance in finding and scheduling an appointment.